Recent Research Analysts’ Ratings Updates for CME Group (CME)

Several brokerages have updated their recommendations and price targets on shares of CME Group (NASDAQ: CME) in the last few weeks:

• 1/7/2025 – CME Group had its price target raised by analysts at Piper Sandler from $250.00 to $258.00. They now have an “overweight” rating on the stock.
• 1/6/2025 – CME Group had its “sector perform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
• 1/6/2025 – CME Group was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $250.00 price target on the stock, down previously from $255.00.
• 12/20/2024 – CME Group had its price target raised by analysts at Keefe, Bruyette & Woods from $237.00 to $260.00. They now have a “market perform” rating on the stock.
• 12/9/2024 – CME Group had its price target raised by analysts at Barclays PLC from $231.00 to $257.00. They now have an “equal weight” rating on the stock.
• 11/11/2024 – CME Group had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $227.00 to $226.00. They now have a “hold” rating on the stock.

CME Group Price Performance

Shares of CME Group stock traded up $1.19 during trading hours on Tuesday, reaching $227.01. The stock had a trading volume of 2,120,989 shares, compared to its average volume of 2,065,580. The firm has a market capitalization of $81.81 billion, a PE ratio of 23.87, a PEG ratio of 5.41 and a beta of 0.56. The stock’s 50 day moving average is $232.33 and its 200 day moving average is $217.92. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $249.02.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the company earned $2.25 EPS. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. Equities analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, January 16th. Stockholders of record on Friday, December 27th will be issued a $5.80 dividend. This is a boost from CME Group’s previous dividend of $2.50. The ex-dividend date of this dividend is Friday, December 27th. CME Group’s dividend payout ratio is presently 48.37%.

Insider Buying and Selling at CME Group

In related news, insider Sunil Cutinho sold 4,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares of the company’s stock, valued at approximately $6,131,291.92. This represents a 14.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of the stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,274 shares of company stock valued at $1,648,071 in the last ninety days. Insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

A number of large investors have recently bought and sold shares of the business. Franklin Resources Inc. boosted its stake in CME Group by 70.4% in the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after purchasing an additional 1,003,119 shares during the period. Ameriprise Financial Inc. increased its holdings in shares of CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after acquiring an additional 537,758 shares during the last quarter. International Assets Investment Management LLC lifted its stake in shares of CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after buying an additional 483,618 shares during the last quarter. Janus Henderson Group PLC lifted its position in shares of CME Group by 17.8% during the 3rd quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock worth $554,707,000 after purchasing an additional 380,071 shares during the last quarter. Finally, Baillie Gifford & Co. bought a new stake in shares of CME Group in the third quarter valued at approximately $79,692,000. Institutional investors own 87.75% of the company’s stock.

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.